Share this

Scotland’s health research biobank celebrates milestone 250,000 blood samples

Scotland’s health research biobank celebrates milestone 250,000 blood samples

Through the collective power of a simple blood sample, people in Scotland are supporting crucial advancements in healthcare research

The Scottish Health Research Register (SHARE) was first created in 2011, enabling volunteers to sign up to be contacted about health research.

Two years later, it was extended to include the Biobank as a unique way to gather biological samples for research with new volunteers joining SHARE able to agree to their blood samples being collected, enabling the Biobank to grow.

Since then, over 250,000 blood samples have been collected to support research with one of the most distinguishing features being that no additional procedures need to be undertaken by participants.

Should a SHARE volunteer who has agreed to blood collection require a routine blood test at their GP surgery or hospital, leftover blood that would normally be discarded can be automatically intercepted, anonymised, and stored in the SHARE Biobank. This process is facilitated by NHS blood sciences laboratories.

Once collected, the samples are de-identified and can undergo laboratory processing, such as the extraction of DNA and protein components for future medical and genetic studies, following strict protocols to ensure the safe, secure and ethical use of samples.

Assisting studies across multiple therapy areas

This rich resource allows health care researchers to apply to the SHARE Biobank to access the stored surplus blood samples, blood components, extracted genetic material and data, with the Biobank assisting studies across multiple therapy areas including diabetes, cardiovascular, cancer, respiratory, maternity, multimorbidity, mental health, and dementia.

The achievement was marked with an event at Dundee’s Ninewells Hospital and Medical School, providing an opportunity to reflect on the growth and diversity of the Biobank, and its contribution to medical research.

Professor Colin Palmer, Associate Dean, Research & Chair of Pharmacogenomics at the School of Medicine, and Director of SHARE, spoke on the milestone achievement and paid tribute to NHS colleagues working in blood sciences, championing “how they have innovated and facilitated” the Biobank.

He highlighted SHARE’s population-wide approach to supporting a broad range of research, and the distinct advantage of linking directly to electronic health records (EHRs), avoiding reliance on self-reported questionnaires, and reducing administrative burden on both participants and researchers.

Biobank impact

Professor Palmer also proudly noted the Biobank’s impact, from studies of multimorbidity, comparisons of disease-specific cohorts with health volunteers, to genetic and biomarker studies without requiring patients to provide additional blood samples.

He cited the example of usage of genotype data to start the rollout of a new stroke treatment across Scotland after it was found that 25% of patients with stroke were receiving treatment that did not work for them.

The Biobank, he said, has played a proud role in “the global explosion of genomic knowledge” and “contributing to our understanding of how our genome works and who we are” using array-based Genome-Wide Association Studies (GWAS)—a research approach used to identify genomic variants that are statistically associated with a risk for a disease or a particular trait.

Professor Palmer added: “We have contributed to a wide range of studies in Scotland, investigating the genetics of common complex diseases including landmark studies on the genetics of diabetes, cardiovascular disease, kidney disease and many others.

“Of course, none of this would have been possible without invaluable individuals consenting to assist researchers in their research endeavours. We are extremely grateful for that.”

Improving understanding and treatments

In 2020, SHARE Biobank blood samples assisted research to identify distinct forms of type 2 diabetes in South Asians, considered to have important implications for prognosis and management of the disease.

SHARE participants aided the research project—a 4-year collaborative global health partnership targeting precision medicine for improved outcomes—by providing anonymised leftover samples for analysis purposes.

This research was part of INSPIRED—a £7 million Dundee-led project which aimed to improve diabetes outcomes, specifically centred around the common and distinct problems of diabetes in India and Scotland, through better understanding of how diabetes develops, how patients respond to medications, and the causes of complications.

More recently, the Biobank has supported researchers across Scotland studying heart disease, liver disease and Alzheimer’s disease. During 2026, samples for six Scottish-led studies have been supported, with two of these studies now being extended to look at metabolic and biological ageing and disease susceptibility.

Collaboration with industry and academia also involved the initial provision of over 300 samples to support research investigating circulating proteins in blood plasma for biological age determination. Researchers then expanded the scope to 700 SHARE samples that fitted the criteria, and are in the process of submitting two further applications.

The ability to bring the research community and public closer together in Scotland has been key to SHARE’s success since its inauguration and was central to another major milestone earlier this year.

15th anniversary

The SHARE register, established by NRS, celebrated the 15th anniversary of its first sign-ups in July. It continues to grow and be supported by NRS with funding from the Chief Scientist Office (CSO) of the Scottish Government.

Over 314,000 volunteers have signed up to date, signalling their enthusiasm to get involved in health research projects—from online surveys and questionnaires to trials of new treatments and technologies.

Participation is entirely voluntary, and members choose which projects they want to be involved in. As such, SHARE represents a unique and valuable resource for clinical trials, connecting Scottish researchers and volunteers who want to take part in studies that improve the country’s health.

SHARE has also taken a distinctively inclusive approach by encouraging registration from anyone in Scotland aged 11 and older who would like to participate, helping to make SHARE a diverse resource for healthcare research.

Across its 15 years, it has received the backing of well-known Scots including television presenter Lorraine Kelly, champion long-distance runner Eilish McColgan, and former Scotland national football team manager Craig Levein, who have registered and supported its commitment to helping forge the future of healthcare.

Register online today or read more at www.registerforshare.org.

Publication date: 17th November 2026

Author: NHS Research Scotland